Literature DB >> 10711818

Morning increase of whole blood viscosity in obstructive sleep apnea syndrome.

L Nobili1, G Schiavi, E Bozano, F De Carli, F Ferrillo, F Nobili.   

Abstract

OBJECTIVE: Patients affected by obstructive sleep apnea syndrome (OSAS) have an increased risk of cardiovascular diseases such as stroke and myocardial infarction. The pathophysiological mechanisms leading to increased vascular risk are still matter of debate. A relative morning hyperviscosity could be one of the leading mechanisms of cardiovascular morbidity which is actually known to be especially high in the morning hours.
METHODS: Whole blood viscosity (WBV) at seven shear rates, ranging from 0.47 to 118 sec(-1), haematocrit (Hct), and plasma fibrinogen (F) concentration, were measured on venous blood samples in 12 patients with OSAS and in 8 healthy controls at 8-9 p.m. and at 7-8 a.m. the morning after. WBV values were normalized on Hct by the computation of the standardised normal deviate z on the normal database of the laboratory.
RESULTS: No changes were observed in controls. Hct, F and normalized WBV (independently from Hct changes) significantly increased in the morning hours in OSAS patients.
CONCLUSIONS: Viscosity of whole blood increases in the morning in OSAS patients but not in healthy controls. This condition may be related to the increased susceptibility to cerebral ischemia in patients affected by OSAS, particularly evident in the early morning.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10711818

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  18 in total

Review 1.  Coagulability in obstructive sleep apnea.

Authors:  Christina Liak; M Fitzpatrick
Journal:  Can Respir J       Date:  2011 Nov-Dec       Impact factor: 2.409

2.  Sleep-disordered breathing and prothrombotic biomarkers: cross-sectional results of the Cleveland Family Study.

Authors:  Reena Mehra; Fang Xu; Denise C Babineau; Russell P Tracy; Nancy S Jenny; Sanjay R Patel; Susan Redline
Journal:  Am J Respir Crit Care Med       Date:  2010-05-27       Impact factor: 21.405

3.  Day/Night rhythm of hemostatic factors in obstructive sleep apnea.

Authors:  Roland von Känel; Loki Natarajan; Sonia Ancoli-Israel; Paul J Mills; José S Loredo; Joel E Dimsdale
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

4.  Relationship between severity of obstructive sleep apnea and adverse cardiac outcomes in non-diabetic patients presenting with myocardial infarction.

Authors:  Liang-Ping Zhao; Kelvin Loh; Germaine Loo; See-Meng Khoo; Liang Shen; Chi-Hang Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-07       Impact factor: 2.503

Review 5.  Endothelial dysfunction in obstructive sleep apnea.

Authors:  Rohit Budhiraja; Sairam Parthasarathy; Stuart F Quan
Journal:  J Clin Sleep Med       Date:  2007-06-15       Impact factor: 4.062

6.  Obstructive sleep apnoea increases the incidence of morning peak of onset in acute myocardial infarction.

Authors:  Hiroshi Nakashima; Tomoko Henmi; Kazutoshi Minami; Yuzou Uchida; Yoshinori Shiraishi; Tatsuya Nunohiro; Koji Maemura
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-06

7.  Hypercoagulability: another potential mechanism of obstructive sleep apnea-related cardiovascular disease?

Authors:  Nabil M Al Lawati; Najib T Ayas
Journal:  Lung       Date:  2008-04-22       Impact factor: 2.584

8.  Proteomic biomarkers of sleep apnea.

Authors:  Aditya Ambati; Yo-El Ju; Ling Lin; Alexander N Olesen; Henriette Koch; Julien Jacques Hedou; Eileen B Leary; Vicente Peris Sempere; Emmanuel Mignot; Shahrad Taheri
Journal:  Sleep       Date:  2020-11-12       Impact factor: 5.849

9.  Association between sleep apnea severity and blood coagulability: Treatment effects of nasal continuous positive airway pressure.

Authors:  Roland von Känel; José S Loredo; Sonia Ancoli-Israel; Joel E Dimsdale
Journal:  Sleep Breath       Date:  2006-09       Impact factor: 2.816

Review 10.  Obstructive sleep apnea syndrome: blood viscosity, blood coagulation abnormalities, and early atherosclerosis.

Authors:  Domenico Maurizio Toraldo; Francesco Peverini; Michele De Benedetto; Francesco De Nuccio
Journal:  Lung       Date:  2012-10-18       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.